Article
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
2019-11-27
Abstract excerpt
Vincristine is a core chemotherapeutic drug administered to pediatric acute lymphoblastic leukemia patients. Despite its efficacy in treating leukemia, it can lead to severe peripheral neuropathy in a sub-group of the patients. Peripheral neuropathy is a debilitating and painful side-effect that can severely impact an individual’s quality of life. Currently, there are no established predictors of peripheral neurop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e7d4066-db85-50da-b31e-f0b7b562b6de
- DOI
- 10.1101/19013078
